How Arcus Biosciences Aims To Take On Merck In Cancer Treatment

Published 1 month ago Neutral
How Arcus Biosciences Aims To Take On Merck In Cancer Treatment
Auto
Arcus Biosciences shares climbed Tuesday as enthusiasm grows for the biotech company's experimental cancer drug, a rival to Merck.

Continue Reading

View Comments

More News

Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

3 hours ago Neutral

Ripple CTO Explains Bitcoin's Use in Payments Amid Price Potential: Details

4 hours ago Neutral

-15,456,495,096 Shiba Inu (SHIB) in 24 Hours: Not Enough?

5 hours ago Neutral

Epic Bull-Bear Bitcoin Price Forecast Issued by CryptoQuant Founder

5 hours ago Neutral

Consumer Portfolio Services GAAP EPS of $0.20, revenue of $108.4M

6 hours ago Neutral